Funder
Parker Institute for Cancer Immunotherapy National Institute of Health
Doris Duke Charitable Foundation
Damon Runyon Cancer Research Foundation
National Institute of Health
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference150 articles.
1. Jakob, J. A. et al. NRAS mutation status is an independent prognostic factor in metastatic melanoma. Cancer 118, 4014–4023 (2012).
2. Cohen, B. E., Manga, P., Lin, K. & Elbuluk, N. Vitiligo and melanoma-associated vitiligo: understanding their similarities and differences. Am. J. Clin. Dermatol. 21, 669–680 (2020).
3. Clark, W. H. Jr, From, L., Bernardino, E. A. & Mihm, M. C. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 29, 705–727 (1969).
4. Clark, W. H. Jr. et al. Model predicting survival in stage I melanoma based on tumor progression. J. Natl Cancer Inst. 81, 1893–1904 (1989).
5. Clemente, C. G. et al. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77, 1303–1310 (1996).
Cited by
180 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献